Cholesterol Introduced to Concentrated Reagent Chemistry Portfolio
|
By LabMedica International staff writers Posted on 29 Jan 2010 |
Introduction of cholesterol to a chemistry concentrated reagent portfolio will result in reduced turnaround times and increased productivity for high throughput labs.
Cholesterol is the 15th Advia chemistry reagent in a concentrated format. The chemistry concentrated reagents offer up to 3060 tests per wedge, whilst giving identical results to conventional Advia nonconcentrated reagents.
Siemens Healthcare (Erlangen, Germany) introduced the concentrated cholesterol reagent--the 15th Advia chemistry reagent in a concentrated format. Concentrated reagent wedges liberate space on the reagent carousel, allowing laboratories to extend testing repertoire. The consolidation of tests onto the high throughput routine Advia chemistry analyzer is the factor that reduces the turnaround times and increases the laboratory's processing efficiency.
"Fast and predictable turnaround times are both essential requirements of pathology services in the UK," said Ibti Rashid, product manager for clinical chemistry at Siemens Healthcare Diagnostics.
The Siemens Healthcare sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in laboratory diagnostics, medical imaging, medical information technology, and hearing aids. By optimizing clinical workflows for the most common diseases, the company makes healthcare faster, better, and more cost-effective.
Related Links:
Siemens Healthcare
Cholesterol is the 15th Advia chemistry reagent in a concentrated format. The chemistry concentrated reagents offer up to 3060 tests per wedge, whilst giving identical results to conventional Advia nonconcentrated reagents.
Siemens Healthcare (Erlangen, Germany) introduced the concentrated cholesterol reagent--the 15th Advia chemistry reagent in a concentrated format. Concentrated reagent wedges liberate space on the reagent carousel, allowing laboratories to extend testing repertoire. The consolidation of tests onto the high throughput routine Advia chemistry analyzer is the factor that reduces the turnaround times and increases the laboratory's processing efficiency.
"Fast and predictable turnaround times are both essential requirements of pathology services in the UK," said Ibti Rashid, product manager for clinical chemistry at Siemens Healthcare Diagnostics.
The Siemens Healthcare sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in laboratory diagnostics, medical imaging, medical information technology, and hearing aids. By optimizing clinical workflows for the most common diseases, the company makes healthcare faster, better, and more cost-effective.
Related Links:
Siemens Healthcare
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Molecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








